Health Care
UK Approves Pfizer/BioNTech Coronavirus Vaccine; Inoculation To Begin Next Week

The United Kingdom became the first country in the world to approve the highly-acclaimed Pfizer/BioNTech Coronavirus vaccine.
Setting the tone for mass inoculation, the new vaccine is reported to be 95 per cent effective in protecting people from COVID-19.
Read More: Top 5 Facts About Pfizer-BioNTech’s 90%-Effective COVID-19 Vaccine
As per the BBC, the MHRA – Britain’s medicine regulator – stated that the vaccine is 95 per cent effective, and that it is safe to be rolled out.
Eight hundred thousand doses are expected to be available in the UK from next week, and people will be contacted by the NHS for inoculation.
Priority will be given to the elderly, caregivers, and NHS staff – though a rounded priority list is expected to be released soon.
Pfizer had stated earlier in November that as much as 50 million vaccines would hit the global markets before the end of this year, while another 1.3 billion will be supplied to health professionals by 2021.
Named the BNT162b2, the mRNA-based vaccine was jointly developed by American pharmaceutical company Pfizer and German biotech company BioNTech.
Sources: BBC, Pfizer
-
News1 month ago
Offer Price, Overview, Investors: Here’s Everything You Need to Know About Asyad Shipping’s Mega IPO
-
OER Magazines1 month ago
OER, February 25
-
Automotive2 months ago
[REVIEW] A Legend Reinvented: The Nissan Patrol Y63 Blends Heritage with Modern Mastery
-
Alamaliktistaad Magazines1 month ago
Al-iktisaad, February 2025
-
Energy1 month ago
Dubai Supreme Council of Energy Unveils 5th Emirates Energy Award 2023–2025 in Muscat
-
News2 months ago
Oil Prices Rise as Investors Assess New US Tariff Threats
-
News2 months ago
Middle East Emerging as a Key Destination for Sports Tourism
-
News1 month ago
Shell Oman Marketing Company Hosts the 1st Lubricants Technology Conference in Muscat